Unlike direct growth hormone compounds, tesamorelin acts upstream stimulating the pituitary gland to release growth hormone through the body’s natural regulatory pathway. This mechanism preserves hypothalamic-pituitary feedback loops, making it particularly valuable in studies where physiological accuracy is a research priority.

Tesamorelin is most prominently researched in the context of visceral adipose tissue metabolism, where studies have documented its influence on reducing trunk fat accumulation through growth hormone-mediated lipolytic pathways. Beyond metabolic research, it is studied for its effects on IGF-1 levels, lipid metabolism regulation, cognitive function markers, and quality-of-life indicators in growth hormone-deficient research models.

Its well-characterized pharmacological profile, combined with a substantial body of clinical and preclinical literature, makes tesamorelin one of the most thoroughly documented GHRH analogs available for investigational purposes. Each vial is supplied at verified 99%+ purity with full third-party COA documentation.

Molecular Formula: C₂₂₁H₃₆₆N₆₈O₆₇S
Molecular Weight: 5,135.77 g/mol
Storage: Lyophilized at −20°C | Reconstitute under sterile conditions

FOR RESEARCH USE ONLY